AstraZeneca PLC
www.astrazeneca.com
Latest From AstraZeneca PLC
Merck & Co. Joins Competitive BTK Research Space With $2.7bn ArQule Buy
ArQule's lead candidate, ARQ 531, is a novel BTK inhibitor in Phase II development that could work in patients with B-cell malignancies resistant to existing BTK inhibitors like Imbruvica.
Deal Watch: AstraZeneca Continues Divestments By Offloading US/Canada Seroquel Rights
Pharma sells the rights to Germany’s Cheplapharm, which obtained EU/Russia rights in October. Cerecor will acquire Aevi Genomics for $16.1m plus contingent value rights.
Aurinia Closing In On Lupus Nephritis With Voclosporin
Canada’s Aurinia Pharmaceuticals expects to file a US NDA in the first half of next year on the use of its next-generation calcineurin inhibitor, voclosporin, in lupus nephritis, a condition with no approved therapies.
AstraZeneca And Galapagos Shine At The 15th Annual Scrip Awards
The pharma, biotech and allied industries came together in London on 4 December to celebrate another year of achievement at the 15th Annual Scrip Awards, hosted by the broadcaster Fiona Bruce.
Company Information
- Industry
- Pharmaceuticals
- Therapeutic Areas
- Cancer
- Cardiovascular
- Gastrointestinal
- Infectious & Viral Diseases
- Inflammation
- Neurology, Nervous System
- Respiratory, Pulmonary
- Alias(es)
- Ownership
- Public
- Headquarters
-
Worldwide
-
Europe
-
Western Europe
-
UK
-
UK
-
Western Europe
-
Europe
- Company Type
- Big Pharma
- Parent & Subsidiaries
-
AstraZeneca PLC
- Acerta Pharma BV
- Ardea Biosciences Inc.
- Arrow Therapeutics Ltd.
- Astra Arcus
- Astra Draco AB
- Astra GMBH
- Astra Hassle AB
- Astra Japan Ltd.
- AstraZeneca AB
- AstraZeneca KK
- AstraZeneca LP
- AstraZeneca Pharma India Ltd.
- AstraZeneca Pharmaceuticals LP
- AstraZeneca UK Ltd.
- Australian Monoclonal Antibody Development Pty Ltd
- Cambridge Research Biochemicals Inc.
- Cambridge Research Biochemicals Ltd.
- ICI Americas Inc.
- ICI Australia
- KuDOS Pharmaceuticals Ltd.
- Laboratorio Ifesa SA
- MedImmune Inc.
- MedImmune LLC
- Novexel SA
- Omthera Pharmaceuticals Inc.
- Pearl Therapeutics Inc.
- Salick Health Care Inc.
- Simes SRL
- Stuart Disease Management Services
- Stuart Pharmaceuticals Inc.
- Symbicom AB
- Zeneca Agrochemicals
- Zeneca Group PLC
- Zeneca Inc.
- Zeneca Pharma Inc.
- Zeneca Pharmaceuticals
- ZS Pharma Inc.
- Senior Management
-
Pascal Soriot, CEO
Marc Dunoyer, CFO - Contact Info
-
AstraZeneca PLC
Phone: (44) 20 3749 5000
1 Francis Crick Ave.
Cambridge, CB2 0AA
UK
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice